share_log

Galectin Therapeutics(GALT.US)董事增持1,000股普通股股份,价值约3,520美元

Galectin Therapeutics(GALT.US) Director Buys US$3,520 in Common Stock

Futu News ·  May 1 02:55

$Galectin Therapeutics (GALT.US)$ Director Zordani Richard A. Jr. purchased 1,000 shares of common stock on Apr 30, 2024 at an average price of $3.52 for a total value of $3,520.

1714503319128879870.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment